- Global Pharma News & Resources

Current & Future Analysis of Medicinal Cannabis Market with New Business Opportunities Discussed | Leading Players – Canopy Growth Corporation, Insys Therapeutics, Inc

CMI published a business research report on “Medical Cannabis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2021–2027”. Medical Cannabis with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.

Medical Cannabis Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Medical Cannabis Market offers complete, proficient report delivering market research data that is relevant for new market entrants or set up players. Key strategies of the companies operating in the market and their impact analysis have been included in the report.

Request Here PDF Brochure @

Medicinal cannabis, also known as medical marijuana, is used either for the treatment of diseases or to improve their symptoms. The two cannabinoids – delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain diseases or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures. Various governments are involved in legalizing the export of medicinal cannabis product, which in turn is expected to fuel growth of the medical cannabis market. For instance, in January 2018, the Government of Australia allowed cannabis producers in the region to export medicinal cannabis and cannabis products in the global market.

The global medical cannabis market was valued at US$ 3,520.7 million in 2017, and is expected to witness a CAGR of 24.4% over the forecast period (2017 – 2025).

Legalization of medicinal cannabis in various economies is expected to drive the market growth

Some of the major factors driving growth of the market include increasing approval of medicinal cannabis products and increasing research and development activities. For instance, in March 2017, a law that allows the use of cannabis plant was signed by the German parliament. This would in turn allow the healthcare professionals to prescribe medicinal cannabis products to the patients suffering from severe health issues such as chronic pain, vomiting, and nausea.

However, excessive consumption of cannabis will induce tachycardia, which will in turn increase the risk of heart attack, especially for users who already suffer from heart disease or arrhythmias. This is expected to hinder growth of the market.

Potential medical cannabis markets other than the U.S. include Canada, Israel, Australia, Mexico, and Spain. For instance, in February 2016, Medical Marijuana, Inc. launched the HempMeds Mexico- a CBD hemp oil product in the Mexico. With the launch of HempMeds Mexico, the company is intended to expand its cannabis business in Latin America. Other economies are also expected to consider legalization of the drug, once conclusive evidence regarding the safety and efficacy of cannabis are obtained through extensive research. Czech Republic, in 2013, legalized medical marijuana for patients suffering from chronic pain, epilepsy, chemotherapy induced side effects, and other severe disease indications. Moreover, the law allows patients with marijuana prescription to purchase medicinal marijuana from pharmacies. However, cultivation of marijuana in not allowed in the country and thereby suppliers need to import medicinal cannabis from other economies.

In Middle East, among the GCC economies, only Israel has approved the medical cannabis product. Furthermore, in Africa, Lesotho and Malawi governments have granted the license for medicinal marijuana in 2017. For instance, in June 2017, Verve Dynamics, a Cape Town-based alternative medicines company received license from the Government of Lesotho to cultivate the cannabidiol (CBD) medicinal cannabis. Verve Dynamics intends to cultivate and produce medicinal cannabis products and export these product to South Africa.

Expansion of medicinal cannabis products by various manufacturers is a prominent factor fueling the market growth

Medicinal cannabis manufacturers in the U.S. are actively focusing on expansion of their medicinal cannabis product business. For instance, in July 2016, Insys Therapeutics, Inc. received the U.S. Food and Drug Administration (FDA) approval for dronabinol oral solution- Syndros, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol. The Syndros is indicated for the treatment of anorexia associated with weight loss among patients suffering from AIDS and those suffering from cancer, chemotherapy-induced nausea, and vomiting. Moreover, in January 2018, Apria, Inc. entered into a distribution agreement with Cannabis Wheaton to supply 60,000 kilograms of the cannabis products between January 2018 and February 2022. The agreement allows Aphria to expand its brand through Cannabis Wheaton’s strong distribution network in Canada.

Some of the key players operating in the global medical cannabis market include, BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc., and Medical Marijuana Inc.

Buy This Complete Business Report With Flat US $2000 Off @

Main points in Medical Cannabis Market Report Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Medical Cannabis Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Medical Cannabis Industry Impact

Chapter 2 Medical Cannabis Competition by Types, Applications, and Top Regions and Countries
2.1 Medical Cannabis (Volume and Value) by Type
2.3 Medical Cannabis (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Medical Cannabis Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Medical Cannabis Market Analysis
Chapter 6 East Asia Medical Cannabis Market Analysis
Chapter 7 Europe Medical Cannabis Market Analysis
Chapter 8 South Asia Medical Cannabis Market Analysis
Chapter 9 Southeast Asia Medical Cannabis Market Analysis
Chapter 10 Middle East Medical Cannabis Market Analysis
Chapter 11 Africa Medical Cannabis Market Analysis
Chapter 12 Oceania Medical Cannabis Market Analysis
Chapter 13 South America Medical Cannabis Market Analysis
Chapter 14 Company Profiles and Key Figures in Medical Cannabis Business
Chapter 15 Medical Cannabis Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology


Request for a Sample Report at –

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 22-Sep-2021